Skip to main content
Premium Trial:

Request an Annual Quote

Despite JRH Acquisition, Sigma Posts Lackluster Organic Revenue Growth in Q1

NEW YORK, April 27 (GenomeWeb News) - Sigma-Aldrich today posted an 8.6-percent increase in first-quarter sales, which grew to $400 million from $368.1 million in the same quarter last year. However, 2.3 percent of that growth was organic.

Sigma attributed 3.2 percentage points of the gain to its recent acquisition of JRH Bioscience's industrial cell culture business. Additionally, 3.1 percent were the result of currency benefits.

The company spent $11.7 million on R&D in the first quarter, up from $10.7 million year over year.

Sigma said that its net income for the first quarter increased 19.7 percent to $74.6 million, or $1.08 per basic share, from $62.3 million, or $.90 per basic share, in the year-ago period.

As of March 31, Sigma had $164.1 million in cash and cash equivalents on hand, the company said.

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.